Search results for "From ACP Diabetes Monthly"
Results 11 - 11 of about 11 for "From ACP Diabetes Monthly".
Sort by:
Relevance
|
Newest
|
Oldest
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022